Arcturus Therapeutics (NASDAQ:ARCT) Financial Overview and Price Target

Posted Mar 10 by John Deo

Thomas Shrader from BTIG set a price target of $48 for NASDAQ:ARCT, indicating a significant potential upside

Source: Two Blokes Trading

GoodRx Holdings, Inc. (NASDAQ:GDRX) Financial Performance Analysis

Posted Mar 10 by John Deo

GoodRx's ROIC of 3.25% is significantly lower than its WACC of 11.62%, indicating inefficient capital utiliza

Source: Two Blokes Trading

Comparative Analysis of ROIC and WACC Across Technology and Business Services Companies

Posted Mar 10 by John Deo

CSG Systems International, Inc. showcases efficient capital utilization with a ROIC of 12.11% and a WACC of 9

Source: Two Blokes Trading

Perpetua Resources Corp. Under Investigation: A Closer Look at Financial Implications

Posted Mar 10 by John Deo

Perpetua Resources Corp. (NASDAQ:PPTA) is currently under investigation by Levi & Korsinsky for potential

Source: Two Blokes Trading

Magnite, Inc. (NASDAQ:MGNI) and Its Financial Efficiency in the Digital Advertising Sector

Posted Mar 10 by John Deo

Magnite's ROIC of 3.19% outperforms its closest peer, PubMatic, showcasing its effectiveness in generating re

Source: Two Blokes Trading

Dick's Sporting Goods (NYSE:DKS) Earnings Preview: Key Insights

Posted Mar 10 by John Deo

Wall Street anticipates an earnings per share (EPS) of $3.49 and revenue of approximately $3.77 billion for t

Source: Two Blokes Trading

Plus Therapeutics, Inc. (NASDAQ:PSTV) Sees Surge After FDA Orphan Drug Designation

Posted Mar 10 by John Deo

Plus Therapeutics, Inc. (NASDAQ:PSTV) stock surged by 311.4% following the FDA's Orphan Drug Designation for

Source: Two Blokes Trading

Plus Therapeutics, Inc. (NASDAQ:PSTV) Sees Surge After FDA Orphan Drug Designation

Posted Mar 10 by John Deo

Plus Therapeutics, Inc. (NASDAQ:PSTV) stock surged by 311.4% following the FDA's Orphan Drug Designation for

Source: Two Blokes Trading

Voyager Therapeutics, Inc. (NASDAQ: VYGR) Quarterly Earnings Preview and Financial Analysis

Posted Mar 10 by John Deo

Earnings per Share (EPS) expected at -$0.35 with revenue projected at $16.6 million. The company's Price-to-E

Source: Two Blokes Trading

Voyager Therapeutics, Inc. (NASDAQ: VYGR) Quarterly Earnings Preview and Financial Analysis

Posted Mar 10 by John Deo

Earnings per Share (EPS) expected at -$0.35 with revenue projected at $16.6 million. The company's Price-to-E

Source: Two Blokes Trading

Vail Resorts, Inc. (NYSE:MTN) Analyst Ratings and Financial Outlook

Posted Mar 10 by John Deo

Barclays downgraded Vail Resorts, Inc. (NYSE:MTN) to "Underweight" with a modest stock price increase of 0.2%

Source: Two Blokes Trading

Groupon, Inc. (NASDAQ: GRPN) Quarterly Earnings Preview

Posted Mar 10 by John Deo

Groupon, Inc. (NASDAQ:GRPN) is a prominent player in the e-commerce marketplace, connecting subscribers with l

Source: Two Blokes Trading